Alexion has gained FDA approval for Kanuma, its treatment for the rare disease lysosomal acid lipase (LAL) deficiency. Alexion says Kanuma (sebelipase alfa) could eventually bring in more than $1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback